Tyrosine Protein Kinase JAK1 Pipeline Review H2 2019 Published by Global...
Tyrosine Protein Kinase JAK1 Pipeline Review H2 2019SummaryTyrosine Protein Kinase JAK1 Janus Kinase 1 or JAK1 or EC 2.7.10.2 pipeline Target constitutes close to 41 molecules. Out of which...
View ArticleHuman medicines European public assessment report EPAR Stelara ustekinumab...
Human medicines European public assessment report EPAR Stelara ustekinumab PsoriasisArthritis PsoriaticCrohn Disease Date of authorisation 15012009 Revision 30 Status Authorised
View ArticlePeptic Ulcers Market Review Epidemiology And Market Forecast 2029 Published...
FirstView Market Insight Peptic Ulcers Market Review Epidemiology And Market Forecast 2029 provides in depth understanding of historical and forecasted epidemiology along with the detailed market...
View ArticleThe European Commission Approves Expanded Use of Janssens STELARAÂ...
The expanded use of ustekinumab addresses a high unmet need among children with moderate to severe plaque psoriasis aged 611 years old for whom there are limited biologic treatment optionsThe Janssen...
View ArticleGossamer Bio Announces Data Presentation at the 2020 Crohns & Colitis Congress
Gossamer Bio Inc. Nasdaq GOSS a clinicalstage biopharmaceutical company focused on discovering acquiring developing and commercializing therapeutics in the disease areas of immunology inflammation and...
View ArticleNFormyl Peptide Receptor 2 Pipeline Review H2 2019 Published by Global...
NFormyl Peptide Receptor 2 Pipeline Review H2 2019SummaryAccording to the recently published report 'NFormyl Peptide Receptor 2 Pipeline Review H2 2019'; NFormyl Peptide Receptor 2 FMLP Related...
View ArticleGenentech Provides an Update on Phase III Study of Tecentriq in People With...
Genentech a member of the Roche Group SIX RO ROG; OTCQX RHHBY today announced that the Phase III IMvigor010 study evaluating Tecentriq atezolizumab as an adjuvant after surgery monotherapy treatment...
View ArticleAlpine Immune Sciences Presents New Preclinical Data at 2020 Crohns & Colitis...
Alpine Immune Sciences Inc. NASDAQALPN a leading clinicalstage immunotherapy company focused on developing innovative treatments for cancer and autoimmuneinflammatory diseases presented new preclinical...
View ArticleReceptor Tyrosine Protein Kinase ERBB 4 Pipeline Review H2 2019 Published by...
Receptor Tyrosine Protein Kinase ERBB 4 Pipeline Review H2 2019SummaryAccording to the recently published report 'Receptor Tyrosine Protein Kinase ERBB 4 Pipeline Review H2 2019'; Receptor Tyrosine...
View ArticleTransient Receptor Potential Cation Channel Subfamily V Member 1 Pipeline...
Transient Receptor Potential Cation Channel Subfamily V Member 1 Pipeline Review H2 2019SummaryTransient Receptor Potential Cation Channel Subfamily V Member 1 Capsaicin Receptor or Vanilloid Receptor...
View ArticleEscalating Stelara Dose Possible in Unresponsive Crohn's
>MedPage Today AUSTIN Dose escalation of ustekinumab Stelara should be considered for patients with Crohn's disease and manifestations of the condition a researcher said here.Among 38 adults with...
View ArticleLanC Like Protein 2 Pipeline Review H2 2019 Published by Global Markets...
LanC Like Protein 2 Pipeline Review H2 2019SummaryAccording to the recently published report 'LanC Like Protein 2 Pipeline Review H2 2019'; LanC Like Protein 2 Testis Specific Adriamycin Sensitivity...
View ArticleAllergan Offloads Two Drugs to Secure Approval of Merger With AbbVie
Allergan is selling off an experimental drug and a commercialized product in order to allay antitrust concerns from regulators reviewing the companys $63 billion acquisition by AbbVie. The rights to...
View ArticleAllergan Sells Zenpep Brazikumab as Regulators Review AbbVie $63B Deal
Allergan has agreed to sell Zenpep pancrelipase to Nestle and return Crohn's disease candidate brazikumab to AstraZeneca as part of ongoing regulatory reviews of AbbVies planned $63 billion...
View ArticleApplications of Immunosequencing in Autoimmunity Upcoming Webinar Hosted by...
Immunosequencing enables incredible insight into the immune system and its role in numerous disease states including autoimmune diseases. Learn how Adaptive Biotechnologies proprietary sequencing...
View ArticleAZ Gets IBD Drug Back From Allergan
Allergan is selling its Crohns disease and ulcerative colitis drug brazikumab back to AstraZeneca to satisfy regulators ahead of its...&160;&160;
View ArticleAbivax to Host Satellite Symposium at 15th Congress of the European Crohn's...
Satellite Symposium will focus on the continued need for innovative drugs in ulcerative colitis the novel mechanism of action of ABX464 as well as clinical data from the Phase 2a induction and...
View ArticleDGAPNews Abivax veranstaltet SatelliteSymposium auf dem 15. Kongress der...
Abivax veranstaltet SatelliteSymposium auf dem 15. Kongress der 'European Crohn's and Colitis Organisation' ECCO in Wien DGAPNews ABIVAX Schlagworte Sonstiges Abivax veranstaltet Satellit...
View ArticleABIVAX Abivax to Host Satellite Symposium at 15th Congress of the European...
Satellite Symposium will focus on the continued need for innovative drugs in ulcerative colitis the novel mechanism of action of ABX464 as well as clinical data from the Phase 2a induction and ma...
View ArticleGlobal Intravenous Sets Market Research 20152019 and Future Forecast 20202025...
SummaryThe report forecast global Intravenous Sets market to grow to reach xxx Million USD in 2019 with a CAGR of xx during the period 20202025.The report offers detailed coverage of Intravenous Sets...
View Article